We are proud to announce that SyVento BioTech is in the spotlight!
An article has appeared on Wyborcza.pl highlighting our innovative achievements in biotechnology and the modern facility we opened in Skawina. With an impressive investment of $100 million, we have become a leader in biotech development in Poland, a fact that has not gone unnoticed by the media.
At SyVento, we specialize in the development and production of vaccines and therapeutic products using groundbreaking mRNA technology. Along with our newly launched production line, with a capacity of 36 million vaccine doses per year, we are one of the most advanced biotechnology centers in the world— one-of-the-kind in Poland and Europe!
To learn more and discover our vision for the future, check out the full article: link
